{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:23:12Z","timestamp":1791926592209,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.bone.2006.10.010","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T22:27:33Z","timestamp":1164839253000},"page":"638-644","source":"Crossref","is-referenced-by-count":95,"title":["Osteogenesis imperfecta type VI in childhood and adolescence: Effects of cyclical intravenous pamidronate treatment"],"prefix":"10.1016","volume":"40","author":[{"given":"Christof","family":"Land","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Travers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis H.","family":"Glorieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2006.10.010_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1359\/jbmr.2002.17.1.30","article-title":"Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect","volume":"17","author":"Glorieux","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.10.010_bib2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2006.10.010_bib3","first-page":"E680","article-title":"Influence of serum Ca concentration on circulating molecular forms of PTH in three species","volume":"251","author":"D'Amour","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bone.2006.10.010_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/8756-3282(94)90888-5","article-title":"Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides","volume":"15","author":"Bollen","year":"1994","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.10.010_bib5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bone.2006.04.004","article-title":"Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment","volume":"39","author":"Land","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.10.010_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jbmr.5650060302","article-title":"Classification of vertebral fractures","volume":"6","author":"Eastell","year":"1991","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.10.010_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1651-2227.1992.tb12152.x","article-title":"Lumbar bone mineral content measured by dual energy X-ray absorptiometry in newborns and infants","volume":"81","author":"Salle","year":"1992","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bone.2006.10.010_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.109.1.45","article-title":"Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version","volume":"109","author":"Ogden","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.bone.2006.10.010_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1203\/00006450-200204000-00017","article-title":"Muscle analysis by measurement of maximal isometric grip force: new reference data and clinical applications in pediatrics","volume":"51","author":"Rauch","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2006.10.010_bib10","first-page":"111","article-title":"Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management","author":"Bleck","year":"1981","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2006.10.010_bib11","article-title":"Pediatric Evaluation of Disability Inventory (PEDI): development, standardization and administrative manual","author":"Haley","year":"1992"},{"key":"10.1016\/j.bone.2006.10.010_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S8756-3282(99)00257-4","article-title":"Normative data for iliac bone histomorphometry in growing children","volume":"26","author":"Glorieux","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.10.010_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.10.010_bib14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bone.2006.02.071","article-title":"Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta","volume":"39","author":"Weber","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.10.010_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2006.10.010_bib16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","article-title":"Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta","volume":"86","author":"Astrom","year":"2002","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bone.2006.10.010_bib17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1210\/jc.2002-021371","article-title":"Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism","volume":"88","author":"Rauch","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.10.010_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bone.2005.07.020","article-title":"The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V","volume":"38","author":"Zeitlin","year":"2006","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328206007861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328206007861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T07:53:53Z","timestamp":1547193233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328206007861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S8756328206007861"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2006.10.010","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}